Mechanisms of myocardial ischemia–reperfusion injury and the cytoprotective role of minocycline: scope and limitations

dc.contributor.author	Thind, Guramrinder S.
dc.contributor.author	Agrawal, Pratik R.
dc.contributor.author	Hirsh, Benjamin
dc.contributor.author	Saravolatz, Louis
dc.contributor.author	Carol Chen-Scarabelli
dc.contributor.author	Narula, Jagat
dc.contributor.author	Scarabelli, Tiziano M.
dc.date.accessioned	2020-12-21T09:46:37Z
dc.date.available	2020-12-21T09:46:37Z
dc.date.issued	2015
dc.identifier.citation	Future Cardiology. 2015; 11(1): 61-76.	en_US
dc.identifier.issn	1479-6678
dc.identifier.uri	http://localhost/xmlui/handle/123456789/1651
dc.language.iso	en	en_US
dc.publisher	Future Medicine Ltd.	en_US
dc.subject	Cytoprotection-drug effects	en_US
dc.subject	HMGB1 protein-drug effects	en_US
dc.subject	Ischemic contracture-physiopathology
dc.subject	Ischemia–reperfusion injury
dc.subject	Minocycline-pharmacology
dc.subject	Matrix metalloproteinases
dc.subject	Mitochondrial membrane transport proteins-physiology
dc.subject	Myocardial reperfusion injury-drug therapy
dc.subject	Mitochondrial permeability transition pore
dc.subject	Mycocardium-pathology
dc.title	Mechanisms of myocardial ischemia–reperfusion injury and the cytoprotective role of minocycline: scope and limitations	en_US
dc.type	Article	en_US